Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 May, 2017 16:20 IST
Lupin receives USFDA nod for generic Seroquel XR tablets
Source: IRIS | 19 May, 2017, 08.20AM
Comments  |  Post Comment

Pharma Major Lupin announced today that it has received final approval for its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg from the United States Food and Drug Administration (FDA) to market a generic version of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

Lupin's Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg are the AB rated generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder alone or as an adjunct to lithium or divalproex; acute depressive episodes in bipolar disorder; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.

Seroquel XR Extended-Release Tablets had US sales of USD 1.27 billion (IMS MAT March 2017).

Shares of the company gained Rs 7.85, or 0.61%, to trade at  Rs 1,304.90.  The total volume of shares traded  was  67,273 at the BSE (4.01 p.m., Thursday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
VA Tech Wabag bags order worth USD 105.5 mn - 23-May-2017 13:23
NIIT Tech enters into partnership with Arago - 23-May-2017 13:19
Zydus Cadilla gets final nod for Cyproheptadine HCl tablets - 23-May-2017 13:09
BHEL commissions 1,980 MW supercritical thermal power project - 23-May-2017 13:07
GAIL Q4 profit plummets 68.7% to Rs 2.6 bn - 23-May-2017 11:33
Tata Power's renewable capacity crosses 2,000 MW - 23-May-2017 11:26
Prakash Industries gets nod for issuing new FCCBs - 23-May-2017 08:12
Karnataka Bank enters into MoU with LIC - 23-May-2017 08:08
Tata Power's generation crosses 52,000 MUs in FY17 - 23-May-2017 08:00
Supreme Infra India bags two EPC projects worth Rs 2.44 bn - 23-May-2017 07:57
HCC's JV secures Rs 6.73 bn order from Rajasthan Govt - 22-May-2017 16:03
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer